Does VEDOLIZUMAB Cause Type 2 diabetes mellitus? 459 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 459 reports of Type 2 diabetes mellitus have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.6% of all adverse event reports for VEDOLIZUMAB.
459
Reports of Type 2 diabetes mellitus with VEDOLIZUMAB
0.6%
of all VEDOLIZUMAB reports
337
Deaths
276
Hospitalizations
How Dangerous Is Type 2 diabetes mellitus From VEDOLIZUMAB?
Of the 459 reports, 337 (73.4%) resulted in death, 276 (60.1%) required hospitalization, and 256 (55.8%) were considered life-threatening.
Is Type 2 diabetes mellitus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 459 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Type 2 diabetes mellitus?
ATORVASTATIN (7,556)
ADALIMUMAB (3,516)
PREDNISONE (3,484)
METHOTREXATE (3,465)
RITUXIMAB (3,318)
TOCILIZUMAB (3,145)
ABATACEPT (3,074)
LEFLUNOMIDE (3,033)
ALENDRONATE (3,002)
DICLOFENAC (2,974)
Which VEDOLIZUMAB Alternatives Have Lower Type 2 diabetes mellitus Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB